Tic Disorder

·MeSH: Tic Disorders

15 drugs in development·13 companies·1 clinical trial

Drug Pipeline by Phase

Approved(15)

Drug	Company
aripiprazole	Mylan II B.V. (MYL)
baclofen	ANI PHARMACEUTICALS INC (ANIP)
fluphenazine	DR REDDYS LABORATORIES LTD (RDY)
hydrocortisone	Impax Laboratories, LLC (IPXL)
risperidone	Prestige Consumer Healthcare Inc. (PBH)
risperidone	Amneal Pharmaceuticals, Inc. (AMRX)
risperidone	REATA PHARMACEUTICALS INC (RETA)
risperidone	Synthorx, Inc. (THOR)
risperidone	AlphaTON Capital Corp (ATON)
risperidone	SUNSET ISLAND GROUP (SUN)
risperidone	Aptinyx Inc. (APTX)
risperidone	ANI PHARMACEUTICALS INC (ANIP)
risperidone	LANNETT CO INC (LCI)
risperidone	PRECISION BIOSCIENCES INC (DTIL)
risperidone	DR REDDYS LABORATORIES LTD (RDY)

BioSniper tracks 15 drugs in development for Tic Disorder across 13 companies.

There are 1 clinical trial targeting Tic Disorder tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.